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Sepsis, an overwhelming inflammatory response syndrome secondary to infection, is 
one of the costliest and deadliest medical conditions worldwide. Neutrophils are classi-
cally considered to be essential players in the host defense against invading pathogens. 
However, several investigations have shown that impairment of neutrophil migration to 
the site of infection, also referred to as neutrophil paralysis, occurs during severe sepsis, 
resulting in an inability of the host to contain and eliminate the infection. On the other 
hand, the neutrophil antibacterial arsenal contributes to tissue damage and the develop-
ment of organ dysfunction during sepsis. In this review, we provide an overview of the 
main events in which neutrophils play a beneficial or deleterious role in the outcome of 
sepsis.
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inTRODUCTiOn
Sepsis represents a challenging health care and economical problem worldwide with lingering 
aftereffects (1). The incidence of sepsis has increased over the last decades (2). In terms of diagnosis, 
sepsis is a systemic response to infection, with increasing severity recognized as severe sepsis or 
septic shock. Severe sepsis is defined as sepsis in the presence of organ dysfunction and septic shock 
as the presence of hypotension unresponsive to vasoconstrictors (3). Intensive preclinical studies 
performed in the last decades have contributed greatly to the understanding the pathophysiology 
of sepsis, though it is not yet fully understood. Neutrophils are important players in the outcome of 
sepsis. Therefore, we will review the involvement of neutrophils in the pathophysiology of sepsis in 
this work.
COnTROL OF inFeCTiOnS BY neUTROPHiLS
Neutrophils are leukocytes with multi-lobed nuclei that form in the bone marrow and are released 
in their mature form to the blood. Neutrophils have a short life span and do not show proliferative 
properties (4, 5).
Classically recognized as phagocytic cells, neutrophils are associated with the innate immune 
response. These cells are recruited to the site of the infection in response to chemotactic mediators, 
where they play antimicrobial roles (5, 6).
FiGURe 1 | neutrophil migration in sepsis. During non-severe sepsis, 
neutrophils expressing CXCR2 are recruited from the blood to the site of 
infection in response to CXCL2 and other chemoattractants. Neutrophils 
migrate to the locale of the infection, where they release NETs and produce 
reactive oxygen and nitrogen intermediates (such as NO) to kill the pathogens 
and avoid its spreading. By contrast, neutrophils are systemically stimulated 
during severe sepsis, which leads to impaired neutrophil migration to the 
infection focus. Bacterial components present in the blood activate TLRs 
expressed on neutrophils, leading to the up-regulation of GRK2, which 
induces desensitization of CXCR2 on the neutrophil surface. Additionally, TLR 
activation induces the expression of TNF-α and iNOS, the latter of which 
might also be activated by PI3K. Both TNF-α and NO can lead to 
upregulation of GRK2, exacerbating the down-regulation of CXCR2 on the 
neutrophil surface. As a consequence, neutrophil migration fails, and bacterial 
growth is not controlled. Furthermore, activation of TLRs also induces the 
expression of CCR2 on the surface of neutrophils, favoring the recruitment of 
these cells to distant organs producing CCL2, which contributes to organ 
damage in association with the capillary occlusion and the hypoperfusion 
observed in sepsis. The systemic activation of neutrophils also induces the 
release of NETs in the blood vessels, which causes endothelial damage, 
culminating in the aggravation of sepsis and possible death. Interestingly, it 
has been demonstrated that IL-33 can prevent the upregulation of GRK2 
expression induced by TLR overactivation and consequently prevent the 
failure of neutrophil migration to the site of infection.
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The presence of neutrophils at the site of infection has been 
demonstrated to be essential for controlling the bacterial and 
fungal burden and avoiding the systemic spread of the infec-
tion (7). Indeed, depletion of neutrophils in mice infected with 
Staphylococcus aureus markedly reduced the clearance of the 
bacteria and also survival (8). Similarly, depletion of neutrophils 
in mice infected with Candida albicans induced dissemination 
of the fungus and led to a higher mortality rate. Likewise, neu-
tropenic patients are more susceptible to bacterial and fungal 
infections (9–11).
Neutrophils induce killing of pathogens via phagocytosis, 
degranulation, or even the release of intracellular components 
such as DNA, histones, and lytic proteins, which form neutrophil 
extracellular traps (NETs) (12, 13). Nitric oxide (NO), a mediator 
produced by the enzyme inducible nitric oxide synthase (iNOS), 
is one crucial mediator of the microbicidal activity of neutrophils. 
Deletion of iNOS induces a high mortality rate due to impaired 
control of the infection, despite the presence of neutrophils in the 
locale of the infection (14).
Additionally, neutrophils are equipped with receptors that 
recognize pathogen-associated molecular patterns or damage-
associated molecular patterns, initiating signaling cascades and 
leading to the production of inflammatory mediators to establish 
an appropriate response against the pathogen. This results in 
amplification of the inflammatory process, including emigration 
of the new waves of neutrophils to the site of infection (15).
Chemokines are a family of small cytokines that are divided 
into small subfamilies based on variations of a conserved cysteine 
motif and play an important role in neutrophil recruitment 
(16). Most chemokines belong to the CC and CXC chemokine 
subfamilies (17), which exhibit two juxtaposed cysteine residues 
or one amino acid between the first two cysteine residues, 
respectively (18). Under physiological conditions, lymphocytes, 
monocytes, and macrophages express CC receptors (CCR) and 
respond to CC chemokines, whereas neutrophils express CXC 
receptors (CXCR)1 (IL-8R in humans) and CXCR2 and respond 
to CXC chemokines (19).
neUTROPHiL MiGRATiOn iS iMPAiReD 
DURinG SeveRe SePSiS
As mentioned above, the control of an infection depends on the 
efficient migration of neutrophils to the site of infection as well as 
appropriate microbicidal activity (20). Our group and others have 
demonstrated that mice subjected to severe sepsis show inad-
equate migration of neutrophils to the site of infection, despite 
the high levels of chemokines at the site. The insufficient number 
of neutrophils recruited to the site of infection does not control 
the infection locally, contributing to the systemic spread of the 
pathogen. As consequence, a marked systemic inflammatory 
response is established, which is associated with high mortality 
rates (21).
Among the mechanisms leading to the failure of neutrophil 
migration, it has been shown that CXCR2 is internalized in 
circulating neutrophils from mice or patients with severe sepsis 
(22–24). Accordingly, neutrophils isolated from septic patients 
show reduced migration toward chemotactic mediators ex vivo, 
which is associated with patient survival: survivors show higher 
neutrophil migration compared with non-survivors (25).
In recent years, several studies have described the mechanisms 
underlying CXCR2 internalization in circulating neutrophils 
during sepsis, resulting in failure of migration to the infectious 
focus (Figure 1) (24, 26–29). It has been reported that chemokine 
receptors belong to the G protein-coupled receptors (GPCRs), 
and their expression is precisely regulated (30). Prolonged 
or repeated exposure to agonists induces desensitization and 
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internalization of GPCRs in a process dependent on the activa-
tion of GPCR kinases (GRKs) (31). GRKs phosphorylate the 
intracellular domains of the activated GPCR, leading to the 
recruitment of arrestin, which decouples the G protein from the 
receptor and trigger its internalization (32). Our group and oth-
ers have demonstrated that ligands of Toll-like receptor (TLR)2, 
TLR4, and TLR9 (lipoteichoic acid (LTA), lipopolysaccharide 
(LPS), and CpG-oligodeoxynucleotide, respectively) induce 
GRK2 upregulation in circulating neutrophils, which in turn, 
leads to CXCR2 internalization (26, 29, 33–35). Indeed, pretreat-
ment of neutrophils with a GRK2 inhibitor prevented the effect 
of TLR4 and TLR9 activation on CXCR2 internalization (33, 34). 
Corroborating these data, tlr2-, 4-, and 9-deficient mice show 
an increase in CXCR2 expression on circulating neutrophils, 
compared with WT mice subjected to severe sepsis (26, 34, 36). 
Additionally, IL-33, a member of the IL-1 family that binds to 
the heterodimeric receptor complex ST2, has been shown to 
prevent the up-regulation of GRK2 mediated by TLR signaling. 
IL-33 treatment improved the recruitment of neutrophils to the 
site of infection in mice and prevented LPS-induced chemotaxis 
reduction in human neutrophils (33, 37).
It is noteworthy that in contrast to the harmful TLR overacti-
vation in circulating neutrophils, adequate activation of TLRs in 
migrated neutrophils is crucial for establishing the local immune 
response. Indeed, tlr4-mutant mice fail to control a low-dose 
infection with the Gram-negative bacterium Salmonella typhimu-
rium (36). Moreover, myd88-deficient mice are highly susceptible 
to polymicrobial sepsis because the lack of the adaptor protein 
involved in most of TLR signaling prevents the establishment 
of the local inflammatory response. In contrast to the TLRs, the 
pattern recognition receptors Nod-like receptors 1 and 2 are not 
involved in neutrophil migration to the site of infection or in 
the establishment of the inflammatory response locale in mice 
subjected to CLP-induced polymicrobial sepsis (38).
Further investigation of how TLRs modulate the expression 
of CXCR2 on the neutrophil surface suggested the involve-
ment of tumor necrosis factor (TNF)-α and NO. Neutrophils 
isolated from tnf receptor-deficient mice activated with LPS do 
not show internalization of CXCR2 or impaired chemotaxis to 
CXCL2. Additionally, neutrophils treated with TNF-α exhibit 
reduced chemotaxis toward CXCL2 (27). Moreover, NO confers 
a similar effect in LPS- or IL-8-stimulated neutrophils. Indeed, 
inhibition of iNOS reduces the effect of the LPS or IL-8 on the 
internalization of CXCR2 and the chemotactic activity of CXCR2 
agonists (24, 29). NO triggers the activation of soluble guanylate 
cyclases (GCs) as well as cyclic-GMP formation and protein 
kinase G  (PKG) phosphorylation (39). As expected, inhibition 
of sGC or PKG had the same effect as iNOS inhibition after LPS 
stimulation of neutrophils. Interestingly, inhibition of sGC and 
PKG during experimental sepsis protected mice from death, and 
this effect was associated with reduced expression of GRK2 in 
neutrophils, increased expression of CXCR2 and, consequently, 
increased neutrophil migration to the infectious focus compared 
with non-treated animals (29).
Based on these observations, we could suggest that TNF-α 
production and/or release in neutrophils is important to the effect 
of TLRs on the CXCR2 expression on these cells. In addition, 
both TLR- and TNF-dependent pathways upregulate inducible 
NO synthase, which could in turn induce GRK2 expression, 
leading to reduced CXCR2 expression on the  neutrophil 
surface (40).
In addition to TNF-α and iNOS, it has been demonstrated that 
phosphoinositide-3 kinase gamma (PI3Kγ) plays an important 
role in this process (28). Interestingly, PI3K may be involved in 
the dimerization of iNOS, an essential process for the activity of 
this enzyme (41). GRK2 upregulation and CXCR2 internalization 
were shown to be inhibited in PI3Kγ−/− neutrophils incubated 
with CXCL2. Additionally, PI3Kγ−/− mice subjected to CLP 
present reduced GRK2 expression and increased CXCR2 expres-
sion on the neutrophil surface, resulting in higher survival rates 
(28). Altogether, these data provide substantial evidence of the 
links between all pathways discussed above and highlight new 
potential targets for sepsis treatment.
In contrast to the deleterious role of the pathways described 
above, there are also mediators that protect the organism against 
sepsis. One example is hydrogen sulfide (H2S), a gas produced 
by the organism that is synthesized from l-cysteine, mainly 
via the cystathionine b-synthase and cystathionine g-lyase 
(CSE) enzymes (42). It has been demonstrated that CSE activ-
ity is increased during sepsis, and inhibition of CSE reduces 
CLP-induced leukocyte–endothelial interactions in mesenteric 
venules, decreases neutrophil migration to the site of infectious, 
and consequently decreases the survival rate of animals sub-
jected to non-severe sepsis (43). In contrast, treatment of mice 
subjected to severe sepsis with an H2S donor has the opposite 
effect, resulting in increased CXCR2 expression on circulating 
neutrophils, increased neutrophil migration to the infection 
focus, and improvement survival (43). Thus, H2S donors could 
be considered for use in sepsis treatment.
Additionally, neutrophil migration events during sepsis have 
been demonstrated to be regulated by several other mediators, 
such as lectin-like oxidized low-density lipoprotein receptor 
(LOX)-1, peroxynitrite, and the acute-phase alpha-1 acid protein, 
which contribute to the failure of neutrophil migration to the site 
of infection (44–46). Conversely, the cytokine IL-17 has been 
shown to be crucial for recruiting neutrophils to the site of infec-
tion during sepsis (47). In contrast, the role of the peroxisome 
proliferator-activated receptor in neutrophil migration during 
sepsis remains to be confirmed, as both protective and deleterious 
role have been described (48, 49). The effects of these mediators 
on the neutrophil migration have been reviewed elsewhere 
(20, 50, 51) and will not be further addressed here.
neUTROPHiL-inDUCeD ORGAn DAMAGe
In addition to the host-protective role of neutrophils in sepsis via 
the killing of microorganisms, these cells have been described as 
exhibiting deleterious functions (6). During sepsis, it has been 
shown that the systemic inflammatory response leads to the acti-
vation of circulating neutrophils sequestered in capillary beds, 
occluding the lumen, and inducing tissue ischemia. Additionally, 
neutrophils can migrate to vital organs and release lytic factors 
and pro-inflammatory cytokines, contributing to organ damage 
and subsequent multiple organ dysfunction (52, 53). Chemokines 
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and chemokine receptors are also involved in the process of 
neutrophil infiltration into vital organs during sepsis. In contrast 
to the observation that CXCR2 is internalized in circulating 
 neutrophils during severe sepsis (24), this receptor has been 
implicated in neutrophil infiltration into the lungs, due to the 
release of CXC chemokines in this organ during sepsis (54, 55). 
This apparent contradiction could be explained by the differences 
in the severity of sepsis induced in each study.
Furthermore, our group and others have demonstrated that 
CCR receptors, which are not expressed on neutrophils under 
physiological conditions, are induced in this cell type in various 
inflammatory processes (56–60). It was demonstrated that CCR2 
is induced on the neutrophil surface in mice and patients with 
sepsis in a TLR2- or TLR4-dependent manner. Importantly, 
CCR2 does not mediate neutrophil recruitment to the site of 
infection, but it does mediate neutrophil infiltration in vital 
organs, such as the lungs, kidneys, and heart. Blockage of CCR2 
decreases organ damage and death in animals subjected to severe 
CLP. Moreover, CCR2 expression is positively correlated with 
the severity of the disease, as measured using the Sepsis-related 
Organ Failure Assessment (SOFA) score. Accordingly, human 
neutrophils isolated from non-surviving septic patients express 
more CCR2 than neutrophils from surviving patients (59).
Another important feature of neutrophils is the formation of 
NETs, a network of chromatin fibers associated with granules of 
antimicrobial peptides and enzymes such as myeloperoxidase, 
elastase, and cathepsin G, which immobilize and kill invading 
microorganisms to prevent their spreading (61). The role of 
NETs in the control of bacterial spreading in sepsis is contro-
versial. Similar bacterial loads were observed in animals lacking 
an important enzyme (peptidylarginine deiminase 4) for NET 
formation and in animals treated with rhDNAse compared with 
control mice (62, 63). However, our group and others (64, 65) 
have observed an important role of NETs in the control of bacte-
rial spreading during sepsis.
In addition to the role of the NETs in bacterial control dur-
ing infection, excessive formation of NETs has been observed in 
many pathological conditions, which is related to organ damage 
(66). Activated endothelial cells induce the formation of NETs 
by neutrophils in  vitro (67, 68). Moreover, in an LPS-induced 
endotoxic shock model, NETs have adhered and activated the 
vascular endothelium (69). Additionally, the interaction between 
neutrophils and activated platelets during sepsis induces NET 
formation, which contributes to endothelial cell damage and 
organ injuries (70). Moreover, it has been reported that histones 
and myeloperoxidase could be responsible for NET-induced 
endothelial dysfunction, and histones can also interact with TLR2 
and TLR4 to induce cytokine production via MyD88 signaling, 
contributing to the systemic inflammatory response observed in 
sepsis (68, 71–74).
Surprisingly, the survival rate was not found to differ between 
rhDNAse-treated and non-treated mice after CLP (65). Further 
investigations revealed that this lack of a difference was due 
to the deleterious role of NETs in organ damage, as discussed 
above. Thus, when antibiotic therapy and rhDNAse treatment 
or inhibition of the enzyme peptidylarginine deiminase 4 were 
used in combination to control a bacterial infection, a marked 
increase in the survival rate of the animals was observed, which 
was associated with decreased organ damage (63, 65). In  addition, 
pretreatment with rh-DNAse in animals challenged with LPS 
decreased the organ damage and increased the survival rate dur-
ing endotoxemia (65).
The observations from mouse models confirm the human 
ones. Notably, autopsy examinations of tissues from septic 
patients with multiple organ dysfunction syndrome indicate the 
presence of neutrophils sequestered into the kidneys and lungs 
(75). Furthermore, severity of acute respiratory distress syndrome 
in septic patients is proportional to the intensity of the inflam-
matory infiltrate and proteolytic enzymes in the bronchoalveolar 
lavage (76).
During sepsis, organ failure is associated with hypoperfusion 
and tissue hypoxia, both of which are attributed to hypotension 
and occlusion of neutrophils in the microcirculation (77, 78). The 
cytokines secreted by neutrophils attached to a vessel wall can 
also cause endothelial dysfunction, establishing a thrombogenic 
profile and favoring intravascular coagulation (79). Additionally, 
neutrophil products can also induce increased NO production 
by various cell types, which can contribute to lowering blood 
pressure (80) and favors the generation of peroxynitrite, a potent 
oxidant agent. In the heart, peroxynitrite can cause changes in 
the structure and function of proteins that may be related to 
sepsis-associated myocardial failure (81). Thus, the adhesion of 
neutrophil to the endothelium and their sequestration to the 
heart may have multiple deleterious cardiovascular effects.
COnCLUSiOn AnD PeRSPeCTiveS
It is clear that sepsis continues to represent a challenge for 
basic and clinical researchers. Despite the massive amount of 
basic and clinical results related to this syndrome that has been 
published in the literature in the last several decades, there has 
been an absence of effective new treatments. The high mortality 
associated with sepsis together with its increased incidence, 
points to the importance of re-evaluation of the literature as 
well as the new translational studies addressing the disease. 
Together, these approaches will help to identify new effective 
targets for the development of new therapies. In this context, 
the present review described the dual roles of neutrophils in 
the evolution of sepsis. These cells are key players in the innate 
immune response in the early phase of sepsis and their recruit-
ment to sites of infection is crucial for controlling microorgan-
ism growth. Aggravation of sepsis is associated with failure of 
neutrophil migration to the site of infection. The molecular 
mechanism involved in this phenomenon was described, and 
several potential targets for the development of new therapies 
were identified. By contrast, neutrophils can be harmful and 
induce secondary organ damage during infection. Neutrophil 
recruitment to organs far from the site of infection is medi-
ated by the expression of CCR2 under septic conditions. The 
mechanism involved in the harmful effect of the neutrophils was 
also described in this review, noting potential targets for the 
development of new therapies. In this context, new therapies 
targeting the harmful activity of neutrophils, such as blocking 
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NET formation or CCR2 activity, might be more helpful than 
targeting the general inflammatory response.
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